- Home
- / I-Mab Biopharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
I-Mab Biopharma financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Stock Price
$1.2
2024-10-29
Market Capitalization
$93.5 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 53.8M | 30.0M | 1.5B | 88.0M | (221.6M) | 27.6M | ||
| Cost of goods sold | 14.9M | 1.1M | ||||||
| Gross profit | 53.8M | 30.0M | 1.5B | 73.1M | (222.7M) | 27.6M | ||
| Gross profit margin, % | 100.0% | 100.0% | 83.1% | 100.5% | 100.0% | |||
| Operating expense total | 485.7M | 1.5B | 1.4B | 2.1B | 1.7B | 1.2B | 51.2M | 94.2M |
| Depreciation and amortization | 6.7M | 15.1M | 22.5M | 31.6M | 60.6M | 213.1M | 261.0K | 68.0K |
| EBITDA | (431.9M) | (1.4B) | 69.4M | (2.4B) | (2.3B) | (1.3B) | (52.2M) | (94.2M) |
| EBITDA margin, % | -4832.9% | 4.5% | -2735.1% | 1059.0% | -4577.8% | |||
| EBIT | (456.2M) | (1.5B) | 470.7M | (2.4B) | (2.3B) | (1.5B) | (50.4M) | (94.2M) |
| EBIT margin, % | -4958.3% | 30.5% | -2739.8% | 1058.2% | -5362.7% | |||
| Interest income | 4.6M | 30.6M | 24.2M | 21.3M | 26.9M | 51.7M | 7.5M | 7.6M |
| Interest expense | 11.7M | 3.0M | 957.0K | 9.0K | 722.0K | |||
| Pre tax profit | (401.1M) | (1.5B) | 483.1M | (2.3B) | (2.5B) | (1.5B) | (49.7M) | (88.3M) |
| Income tax expense | 1.7M | 12.2M | (3.2M) | 697.0K | ||||
| Net Income | (402.8M) | (1.5B) | 470.9M | (2.3B) | (2.5B) | (1.5B) | (49.7M) | (88.3M) |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |